Treatment for Non-Alcoholic Fatty Liver Disease (NAFLD)

Phase-Based Progress Estimates
Non-Alcoholic Fatty Liver Disease (NAFLD)+1 More
All Sexes
What conditions do you have?

Study Summary

This trial is assessing the prevalence of two liver diseases, Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH), and assembling a cohort of adults with these diseases to better understand them.

Eligible Conditions
  • Non-Alcoholic Fatty Liver Disease (NAFLD)
  • Non-alcoholic Fatty Liver Disease (NAFLD)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 5 years

5 years
Long-term health outcomes
Prevalence of NAFLD and NASH in the population

Trial Safety

Trial Design

0 Treatment Group

800 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

Mayo ClinicLead Sponsor
2,918 Previous Clinical Trials
3,506,180 Total Patients Enrolled
ALINA M ALLEN, MDPrincipal InvestigatorMayo Clinic

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are a resident of Olmsted County at the time of search.